Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
30 participants
INTERVENTIONAL
2024-06-17
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II
NCT06269913
A Novel Iron Supplement for Athletes: Phase I
NCT06285851
Improving Iron Levels in Female Endurance, Intermittent, and Power/Strength Athletes Aged 16-35
NCT06942208
How Does a Synbiotic Supplement Affect Iron Status During Iron Repletion in Iron Depleted Female Athletes?
NCT03793959
Exercise and Galactooligosaccharide Supplementation on Inflammation and Iron Absorption (FexerGOS)
NCT06038656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Iron/yeast complex (FeSC)
Iron Supplement
FeSC
Iron/yeast complex
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FeSC
Iron/yeast complex
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* sub-optimal iron status (ferritin ≤45mcg/ L)
* At least 1 year past the age of menarche
* Engage in moderate to vigorous endurance activity for at least 3 hours a week
Exclusion Criteria
* antibiotic use in last 3 months
* \- Energy availability \>30 kcal/kg lean body mass
14 Years
17 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mitacs
INDUSTRY
Natural Sciences and Engineering Research Council, Canada
OTHER
University of Calgary
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jane Shearer
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jane Shearer, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Calgary
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Calgary
Calgary, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-0826.2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.